Key Details
Price
$0.49Annual ROE
41.08%Beta
0.67Events Calendar
Next earnings date:
May 8, 2025Recent quarterly earnings:
Feb 19, 2025Recent annual earnings:
Feb 19, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 20, 25 RBC Capital
OutperformFeb 20, 25 HC Wainwright & Co.
BuyFeb 10, 25 RBC Capital
OutperformJan 15, 25 HC Wainwright & Co.
BuyNov 6, 24 Piper Sandler
OverweightNov 6, 24 HC Wainwright & Co.
BuyNov 1, 24 HC Wainwright & Co.
BuyAug 7, 24 RBC Capital
OutperformAug 7, 24 HC Wainwright & Co.
BuyAug 7, 24 Baird
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Karyopharm Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Karyopharm Therapeutics?
- Does Karyopharm Therapeutics pay dividends?
- What sector is Karyopharm Therapeutics in?
- What industry is Karyopharm Therapeutics in?
- What country is Karyopharm Therapeutics based in?
- When did Karyopharm Therapeutics go public?
- Is Karyopharm Therapeutics in the S&P 500?
- Is Karyopharm Therapeutics in the NASDAQ 100?
- Is Karyopharm Therapeutics in the Dow Jones?
- When was Karyopharm Therapeutics's last earnings report?
- When does Karyopharm Therapeutics report earnings?
- Should I buy Karyopharm Therapeutics stock now?
What is the ticker symbol for Karyopharm Therapeutics?
The ticker symbol for Karyopharm Therapeutics is NASDAQ:KPTI
Does Karyopharm Therapeutics pay dividends?
No, Karyopharm Therapeutics does not pay dividends
What sector is Karyopharm Therapeutics in?
Karyopharm Therapeutics is in the Healthcare sector
What industry is Karyopharm Therapeutics in?
Karyopharm Therapeutics is in the Biotechnology industry
What country is Karyopharm Therapeutics based in?
Karyopharm Therapeutics is headquartered in United States
When did Karyopharm Therapeutics go public?
Karyopharm Therapeutics's initial public offering (IPO) was on November 6, 2013
Is Karyopharm Therapeutics in the S&P 500?
No, Karyopharm Therapeutics is not included in the S&P 500 index
Is Karyopharm Therapeutics in the NASDAQ 100?
No, Karyopharm Therapeutics is not included in the NASDAQ 100 index
Is Karyopharm Therapeutics in the Dow Jones?
No, Karyopharm Therapeutics is not included in the Dow Jones index
When was Karyopharm Therapeutics's last earnings report?
Karyopharm Therapeutics's most recent earnings report was on Feb 19, 2025
When does Karyopharm Therapeutics report earnings?
The next expected earnings date for Karyopharm Therapeutics is May 8, 2025
Should I buy Karyopharm Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions